我国银屑病患者人群庞大,目前银屑病治疗已有很大发展,但仍有许多患者的需求未能得到满足。
参考文献:
[1] Parisi R, et al. J Invest Dermatol 2013;133:377
[2] DING X,WANG T,SHEN Y,et al.Prevalence of psoriasis in China: a population-based study in six cities[J].Eur J Dermatol,2012,22( 5) :663667.
[3] 丁晓岚等.中国六省市银屑病流行病学调查.中国皮肤性病学杂志,2010(7):598-601.
[4] 中国银屑病疾病负担和患者生存质量调研
[5] OBRADORSM,BLANCH C,COMELLAS M,et al.Healthrelated quality of life in patients with psoriasis: a systematic review of the European literature[J].Qual Life Res,2016,25(11) :27392754.
[6] 刘翌,常见民.银屑病患者抑郁症状检出情况及影响因素调查分析[J].皮肤性病诊疗学杂志,2016,23(5):310313.
[7] 江艳,郭妙兰,邱晓瑜.寻常型银屑病患者自我感受负担的现状与影响因素[J].皮肤性病诊疗学杂志,2017,24(5) :331334.
[8] DALGARDFJ,GIELER U,TOMAS-ARAGONES L,et al.The psychological burden of skin diseases: a crosssectional multicenter study among dermatological out-patients in 13 European countries[J].J Invest Dermatol, 2015,135( 4) :984991.
[9] EGEBERG A,HANSEN P R,GISLASON G H,et al.Risk of self-harm and nonfatal suicide attempts,and completed suicide in patients with psoriasis: a populationbased cohort study[J].Br J Dermatol,2016,175( 3) :493500.
[10] U. Mrowietz et al. Definition of treatment goals for moderate to severe psoriasis:a European consensus[J]. Arch Dermatol Res (2011) 303:1–10.
[11] 中华医学会皮肤性病分会银屑病学组. 中国银屑病治疗指南(2014版)[J]. 中华皮肤科杂志, 2014,47(3):213-215.
[12] Puig L, et al. Clinicoecon Outcomes Res 2014;6:93.
[13] Takeshita J, et al. J Invest Dermatol 2015;135:2955.
[14] Lebwohl M, et al. J Am Acad Dermatol 2014;70:871.
[15] DEVAUX S,CASTELA A,ARCHIER E,et al.Adherence to topical treatment in psoriasis: a systematic literature review[J].J Eur Acad Dermatol Venereol,2012,26 ( suppl 3) :6167.
[16] Elewski BE, et al. J Dermatolog Treat 2017;28:492.
[17] J.Zhang,et al.28th European Academy of Dermatology and Venereology Congress, 9-13 October,2019,Madrid, Spain,#P1600.
张建中 教授
北京大学人民医院皮肤科主任,
中华医学会皮肤性病学分会第十三届主任委员
中国康复医学会皮肤性病学分会主任委员
亚洲皮肤科学会理事
国际特应性皮炎研究会理事
世界华人医师协会皮肤科医师协会副会长
中国医师协会皮肤性病学分会副会长
MCC号CXO2005928有效期2021-05-10,资料过期,视同作废。
联系客服